All Articles

The nation's largest landscaper affirms its financial health by paying an $8.8M cash dividend, avoiding share dilution and signaling confidence to investors.

Crane NXT adds Benchmark Electronics CEO Jeffrey Benck to its board, signaling a strategic pivot towards deeper tech expertise as a veteran director departs.

The organic kids' food brand reports impressive sales and a strong IPO, but investors are keenly watching its strategy for long-term profitability.

Shimmick reports a second straight quarter of positive EBITDA, signaling its strategic shift to core infrastructure is paying off despite a net loss.

Universal Electronics is restructuring for profitability amid falling sales, raising questions about the future of the connected home market.

Lucara Diamond Corp. finalizes a massive financing package for its Karowe mine expansion, averting a crisis but taking on costly debt to secure its future.

After a strategic pivot and R&D setbacks, Korro Bio secures an $85M lifeline to advance its novel RNA-editing drug for rare metabolic diseases.

A cult-favorite St. Louis creamery, fueled by a $6M investment from a franchise titan, is set to go national with an innovative model for franchisees.

Hydrafacial's parent company posts a massive jump in profitability for 2025, but slowing device sales and cautious guidance raise questions for 2026.

Data shows Beren Therapeutics' drug slows progression and boosts survival for infantile-onset NPC, a rare disorder with no approved US treatments.

Colgate-Palmolive signals confidence with its 63rd annual dividend hike and appoints Bristol Myers Squibb's CEO to its board, a strategic health pivot.

After a tough 2025, the gaming giant touts record margins and an aggressive 2026 plan, betting on new gear and a massive market catalyst for growth.

PitchBook integrates its private market data into Perplexity's AI, promising a new era of fast, verifiable, and conversational financial intelligence.

Maker's Pride is closing two Midwest facilities as part of a strategic shift to automation, leaving communities in Utah and Minnesota facing an uncertain future.

Amid a complex healthcare market, The Ensign Group will outline its aggressive growth and operational playbook for investors at the upcoming Oppenheimer conference.

A manufacturing flaw in some Omnipod 5 insulin pods has caused serious health issues, prompting a company response and raising questions about device safety.

The Joint Corp. posts higher profits through a major franchise pivot, but declining patient visits and sales raise questions about its long-term health.

As FGI Industries prepares its 2025 results, investors watch for clues on the health of the home improvement sector amid economic uncertainty.

Strathcona Resources to repurchase up to 5% of its shares, calling them undervalued. The move signals strong confidence and boosts shareholder value.

A coalition of 20 organizations has petitioned the state to ban lead ammunition, citing overwhelming evidence of harm to eagles, wildlife, and humans.